Kodiak Sciences Inc.(KOD)
盘前39.53-0.23-0.59%08:15 EDT
39.76+17.01+74.77%
行情数据延迟15分钟
- 最新
- 推荐
暂无内容公司概况
公司名称Kodiak Sciences Inc.所属市场NASDAQ成立日期- -员工人数- -办公地址- -邮政编码- -联系电话- -联系传真- -公司概况Kodiak Sciences Inc.于2009年6月22日以Oligasis LLC的名义成立为有限责任公司。2015年9月8日更名并在特拉华州注册成立公司。该公司是一家临床阶段的生物制药公司，专门研究治疗慢性高流行性视网膜疾病的新疗法。Kodiak Sciences Inc.最先进的候选产品是KSI-301，这是一种使用公司抗体生物聚合物偶联平台（ABC Platform）构建的生物疗法，旨在维持眼组织中有效且有效的药物水平。- 2025-12-18Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-11-13Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2025-11-13Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-08-14Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2025-08-14Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-06-04Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-05-15Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2025-05-14Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-03-27Form S-8 - Securities to be offered to employees in employee benefit plans员工持股计划Form S-8 - Securities to be offered to employees in employee benefit plans
- 2025-03-27Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]年度报告Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
- 2025-03-27Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2024-11-15Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2024-11-15Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2024-08-15Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2024-08-15Form 8-K - Current report重要事件披露Form 8-K - Current report
- 分时
- 5日
- 日
- 周
- 月
数据加载中...
最高
40.46
今开
35.41
量比
13.45
最低
33.50
昨收
22.75
换手率
35.75%